Physician profile
Daniel W Weed
NPI 1194725937
$963.65
in general payments reported to CMS, 2019-2025
10 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2021: $313 · 2022: $14.25 · 2023: $43.60 · 2024: $121 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $187.88 | 2021 | |
| Icotec Medical INC. | $163.50 | 2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Boston Scientific Corporation | $132.27 | 2025 | Spaceoar Vue System - 10ml |
| Glaxosmithkline, LLC. | $124.99 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $123.92 | 2019 | |
| Amgen INC. | $121.18 | 2024 | |
| Iba Proton Therapy, INC. | $43.60 | 2023 | |
| Tactile Systems Technology INC | $29.78 | 2019 | |
| Mevion_medical_systems_inc | $22.28 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Weed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.